Moderna has outperformed many of its peers and the broader market YTD, but Wall Street analysts are cautiously optimistic about the stock's prospects.
Amgen has outperformed the broader market and many of its peers over the past year, but Wall Street analysts believe it has limited upside left.
VanEck Launches Robotics ETF (IBOT)
VanEck today announced the launch of the VanEck Robotics ETF (IBOT) , a thematic equity ETF offering exposure to the leading global companies that are driving and benefiting from the growth of the robotics...
BBH Crosses Critical Technical Indicator
In trading on Wednesday, shares of the Biotech ETF entered into oversold territory, changing hands as low as $150.5312 per share. We define oversold territory using the Relative Strength Index, or RSI,...